• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
0.32% $15.62

CLINUVEL PHARMACEUTICALS LIMITED

Market Cap $782.6M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV
Ann: Syd Capital Markets Briefing Presentation 		19:59 33 11K
19:59 Last post  Niamh Comments Created with Sketch.  33  Views Created with Sketch.  11K 
CUV
Shorts are trapped 		26/05/24 15 4.3K
26/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  15  Views Created with Sketch.  4.3K 
CUV
Time for a Change 		25/05/24 2 683
TRENDING NEWS

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Read More   right-arrow Created with Sketch.
NEWS
27 May 2024
25/05/24 Last post  Eagle0 Comments Created with Sketch.  2  Views Created with Sketch.  683 
CUV
Ann: Ceasing to be a substantial holder 		24/05/24 0 367
24/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  367 
CUV
Fundies are Loading Up 		24/05/24 10 2.4K
24/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  10  Views Created with Sketch.  2.4K 
CUV
38 days to cover short positions = nice setup 		24/05/24 6 1.7K
24/05/24 Last post  F18FDG Comments Created with Sketch.  6  Views Created with Sketch.  1.7K 
CUV
13% since March and uncorrelated to other holdings 		24/05/24 2 686
24/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  2  Views Created with Sketch.  686 
CUV
Ann: CLINUVEL and Valentech enter Latin American partnership 		23/05/24 6 1.9K
23/05/24 Last post  cuv101 Comments Created with Sketch.  6  Views Created with Sketch.  1.9K 

See All Discussions arrow Created with Sketch.

Timeline

Ceasing to be a substantial holder
24 May 18:06
 
CLINUVEL and Valentech enter Latin American partnership
23 May 09:57
 
Update - Notification of buy-back - CUV
14 May 09:07
 
Becoming a substantial holder
14 May 08:18
 
Update - Notification of buy-back - CUV
10 May 09:08
 
Update - Notification of buy-back - CUV
09 May 09:13
 
View More arrow Created with Sketch.

Featured News

TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
BCA Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya
right-arrow Created with Sketch.
VMS Venture hits 1,839 TREO at Jupiter in WA with best intersection to date
right-arrow Created with Sketch.
NMT Neometals eyeing 80% stake in US-based precious metal waste recovery plant
right-arrow Created with Sketch.
DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.
(20min delay)
Last
$15.62 		Change
0.050(0.32%) 		Mkt cap ! $782.6M
Open High Low Value Volume
$15.60 $15.67 $15.49 $394.1K 25.28K

Buyers (Bids)

No. Vol. Price($)
4 225 $15.60
 

Sellers (Offers)

Price($) Vol. No.
$15.67 640 1
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
$15.63 		  Change
0.050 ( 0.26 %)
Open High Low Volume
$15.63 $15.67 $15.49 2293
Last updated 15.59pm 27/05/2024 ?
CUV (ASX) Chart

Top Stories

Market Close: ASX edges up with mostly smiles on green dials

The ASX200 closed the day up 0.8%.All sectors bar one finished in the green. Real-estate lead the way, up 1.8%, tele-communications and staples followed, both gaining around 1.3%.The energy sector was the only sector to fall short, down 0.2%In the greenSayona Mining (ASX:SYA) gained 4.75% after i...
Beamtree score $3.6M contract to expand hospital technology into Saudi Arabia Beamtree Holdings Ltd has achieved a $3.6 million contract which will see it expand its AI technology into hospitals in Saudi Arabia.
Market Update: ASX turns green with real estate flowering The ASX200 is trading up around 0.7 per cent.Most sectors are in the green, real estate has gained the most so far, up nearly 1.6%. Staples follows, up 1.2%.The utilities and energy sectors are the only two to slip into the red.Company newsReal estate company, Lendlease (ASX:LLC) is up nearly 10%...
Critical minerals bounty in Angola points to prospect extension for Tyranna Tyranna Resources Ltd has picked up high grades in lithium, tantalum and caesium based on drilling at its Muvero prospect in Angola.
Elixir reports rise of 328% in contingent resources at QLD gas project Elixir Energy Ltd has reported an upgrade of 328% in its contingent resources at Queensland's Grandis Gas Project.

Featured News

ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
right-arrow Created with Sketch.
TLM Talisman expands Rip n Tear with lead grading 7.4% and silver at 59.2g/t in NSW
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
PLY PlaySide to take gamers back to Westeros with new PC title
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.